{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T23:02:30Z","timestamp":1700002950864},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.contraception.2008.04.001","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T11:19:30Z","timestamp":1212491970000},"page":"113-119","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo"],"prefix":"10.1016","volume":"78","author":[{"given":"Alfred","family":"Poindexter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen Z.","family":"Reape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Hait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.04.001_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humupd\/8.4.345","article-title":"Residual ovarian activity during oral steroid contraception","volume":"8","author":"Van Heusden","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2008.04.001_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1701-2163(16)30692-2","article-title":"Ovarian follicular development during the use of oral contraception: a review","volume":"26","author":"Baerwald","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2008.04.001_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2004.05.006","article-title":"Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use","volume":"70","author":"Baerwald","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/er.18.1.71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2008.04.001_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0002-9378(98)70292-3","article-title":"Ovarian activity in women taking an oral contraceptive containing 20 mcg ethinyl estradiol and 150 mcg desogestrel: effects of low estrogen doses during the hormone-free interval","volume":"179","author":"Killick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.04.001_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.04.001_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2007.09.010","article-title":"Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive","volume":"77","author":"Reape","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib9","unstructured":"Mircette [NDA 20 713] Montvale (NJ): Duramed Research, Inc.; 1998. Available at: http:\/\/www.fda.gov\/cder\/foi\/nda\/98\/20713.htm. [Accessed January 29, 2008]."},{"key":"10.1016\/j.contraception.2008.04.001_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: Phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 mg (Loestrin Fe)","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.04.001_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives; collaborative reanalysis of individual data on 53,597 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.04.001_bib14","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2008.04.001_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2008.04.001_bib16","unstructured":"ACOG Practice Bulletin, Number 42, April 2003. Breast Cancer Screening. Available at: http:\/\/www.guideline.gov\/summary\/summary.aspx?ss=15&doc_id=3990 [Accessed February 13, 2008]."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T23:23:46Z","timestamp":1545953026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0010782408001339"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.04.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}